As prodromal AD was suspected, the patient underwent cerebrospinal fluid (CSF) biomarker evaluation which was not consistent with AD (negative for brain amyloidosis while mildly positive for both tau pathology and neurodegeneration: A-T + N +) [1]. The gene discussed is MAPT; the disease is Alzheimer disease.